india tirzepatide A diabetes drug just overtook fever & cold medicines to become India’s second biggest pharma brand. But it’s not diabetes driving sales — it’s weight loss., @Meghamukundan_ explains Mounjaro’s boom & Study looks into which weight-loss

Schulz JB, Lindenau J, Seyfried J, Dichgans J

The Food and Drug Administration is considering removing the shortage status of Wegovy, which may stop compounding pharmacies from creating less expensive copies

References Clinical trials utilize multiple methods of tracking, categorizing, and assessing any side effects at each trial stage

It's very important to speak with your healthcare provider before you stop taking it

(6) neurotrophic agents offer the ability to facilitate synaptogenesis, neurogenesis and neuroprotection thus greater research attention must be directed toward creating small molecule analogs designed to penetrate the BBB and activate these brain systems